<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The microfibrillar protein fibrillin-1 is a component of the mesangial matrix </plain></SENT>
<SENT sid="1" pm="."><plain>Defects in fibrillin-1 predisposes individuals to vascular damage in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, but the role of fibrillin-1 in <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that fibrillin-1 is involved in hypertensive or diabetic <z:e sem="disease" ids="C0268731" disease_type="Disease or Syndrome" abbrv="">glomerular disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>DOCA-salt <z:hpo ids='HP_0000822'>hypertension</z:hpo> or <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> (STZ) <z:mp ids='MP_0002055'>diabetes</z:mp> led to a significant increase in glomerular fibrillin-1 deposition </plain></SENT>
<SENT sid="4" pm="."><plain>To test the functional role of fibrillin-1, DOCA <z:hpo ids='HP_0000822'>hypertension</z:hpo> and STZ <z:mp ids='MP_0002055'>diabetes</z:mp> were induced in mice homozygous for a mutation leading to a fivefold lower expression of fibrillin-1 (mgR/mgR) </plain></SENT>
<SENT sid="5" pm="."><plain>Untreated male mgR/mgR mice usually die from <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> during the first 4 mo of life </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> DOCA-treated mgR/mgR mice died within 2 wk after <z:hpo ids='HP_0003674'>onset</z:hpo> of DOCA treatment </plain></SENT>
<SENT sid="7" pm="."><plain>DOCA-treated heterozygous (mgR/+) and their <z:mp ids='MP_0002169'>wild-type</z:mp> littermates displayed similar blood pressure levels, but <z:mp ids='MP_0002871'>albuminuria</z:mp> was significantly lower in mgR/+ than in <z:mp ids='MP_0002169'>wild-type</z:mp> mice after DOCA treatment </plain></SENT>
<SENT sid="8" pm="."><plain>Similarly, STZ diabetic mgR/mgR and mgR/+ developed lower <z:mp ids='MP_0002871'>albuminuria</z:mp> than <z:mp ids='MP_0002169'>wild-type</z:mp> mice despite higher blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels in mgR/mgR and mgR/+ compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="9" pm="."><plain>Blood pressure, blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, and <z:mp ids='MP_0002871'>albuminuria</z:mp> did not differ among untreated mgR/mgR, mgR/+, and <z:mp ids='MP_0002169'>wild-type</z:mp> mice, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>In diabetic mgR/+ and mgR/mgR, but not in <z:mp ids='MP_0002169'>wild-type</z:mp> mice, an induction of glomerular decorin expression was observed </plain></SENT>
<SENT sid="11" pm="."><plain>Thus underexpression of fibrillin-1 predisposes individuals to lethal <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> in the presence of <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>On the other hand, <z:mp ids='MP_0002871'>albuminuria</z:mp> as a parameter of microvascular damage in <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> was ameliorated in fibrillin-1-underexpressing mice, possibly due to a compensatory upregulation of decorin </plain></SENT>
<SENT sid="13" pm="."><plain>We conclude that fibrillin-1 may contribute to glomerular damage in hypertensive and <z:e sem="disease" ids="C0011881" disease_type="Disease or Syndrome" abbrv="">diabetic kidney disease</z:e> </plain></SENT>
</text></document>